目的:研究替米沙坦對合并高血壓的陣發性房顫患者轉復為竇性心律后復發的影響。方法: 選擇84例合并高血壓的陣發性房顫患者,隨機分成觀察組及對照組,觀察組降壓藥使用替米沙坦,對照組使用氨氯地平,兩組均使用胺碘酮復律,隨訪2年,觀察兩組患者的療效及超聲心動圖(左房內徑)變化。結果:觀察組治療合并高血壓的陣發性房顫復發率顯著低于對照組。結論:替米沙坦聯合抗心律失常藥物,能有效防止房顫復發,維持竇性心律。
Citation：
XU Li,BAI Ping.. Clinical Study on Telmisartan for the Treatment of Paroxysmal Atrial Fibrillation with Hypertension. West China Medical Journal, 2009, 24(8): 2130-2131. doi:
Copy
Copyright ? the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved
| 1. |
杜昕,馬長生.心房顫動的再認識(一)[J].中國心血管病研究雜志,2005, 3(10): 725-727.
|
| 2. |
AUSMA J,DISPERSYN G,HANSD,et al. Changes in ultrastructural calcium distribution in goat atrial during atrial fibrillation[J].Mol Cell Cardiol,2000,32: 355-359.
|
| 3. |
戚文航. 血管緊張素受體拮抗劑與心房顫動[J].中華心血管病雜志, 2004,32 (11): 1042-1043.
|
| 4. |
HIDEKO N, KOICKIRO K,HIDENORI U, et al. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation[J]. Circulation,2000,101: 2612-2617.
|
- 1. 杜昕,馬長生.心房顫動的再認識(一)[J].中國心血管病研究雜志,2005, 3(10): 725-727.
- 2. AUSMA J,DISPERSYN G,HANSD,et al. Changes in ultrastructural calcium distribution in goat atrial during atrial fibrillation[J].Mol Cell Cardiol,2000,32: 355-359.
- 3. 戚文航. 血管緊張素受體拮抗劑與心房顫動[J].中華心血管病雜志, 2004,32 (11): 1042-1043.
- 4. HIDEKO N, KOICKIRO K,HIDENORI U, et al. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation[J]. Circulation,2000,101: 2612-2617.
